BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11787344)

  • 1. [Value of MRI in patients with multiple sclerosis].
    Tourbah A
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1124-7. PubMed ID: 11787344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A
    Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of follow-up and evolution of multiple sclerosis].
    Couvreur G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1143-51. PubMed ID: 11787348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging in multiple sclerosis. A review.
    Truyen L
    Acta Neurol Belg; 1994; 94(2):98-102. PubMed ID: 8036883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging in the diagnosis and follow-up of patients with multiple sclerosis.
    Paty DW
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):125-31. PubMed ID: 1345733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria.
    Simó M; Barsi P; Arányi Z
    Mult Scler; 2008 May; 14(4):472-8. PubMed ID: 18208873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of MRI as an outcome measure in clinical trials.
    Li DK; Li MJ; Traboulsee A; Zhao G; Riddehough A; Paty D
    Adv Neurol; 2006; 98():203-26. PubMed ID: 16400836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.
    Zipoli V; Hakiki B; Portaccio E; Lolli F; Siracusa G; Giannini M; Pantoni L; Pescini F; Sorbi S; Amato MP
    Mult Scler; 2009 Apr; 15(4):472-8. PubMed ID: 19153171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Magnetic resonance and multiple sclerosis II. New diagnostic techniques].
    Mathiesen HK; Langkilde AR; Larsson HB
    Ugeskr Laeger; 2002 Feb; 164(8):1031-6. PubMed ID: 11894703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic criteria of multiple sclerosis in neuroimaging].
    Berry I
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):944-8. PubMed ID: 11787359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of MRI in the diagnosis of multiple sclerosis.
    Traboulsee AL; Li DK
    Adv Neurol; 2006; 98():125-46. PubMed ID: 16400831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
    Goodin DS
    Ann Neurol; 2006 Apr; 59(4):597-605. PubMed ID: 16566022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
    Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M
    Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic resonance and multiple sclerosis I. Conventional diagnostic techniques].
    Mathiesen HK; Langkilde AR; Larsson HB
    Ugeskr Laeger; 2002 Feb; 164(8):1026-31. PubMed ID: 11894702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.
    Bar-Zohar D; Agosta F; Goldstaub D; Filippi M
    Mult Scler; 2008 Jul; 14(6):719-27. PubMed ID: 18424478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.
    Agosta F; Rovaris M; Pagani E; Sormani MP; Comi G; Filippi M
    Brain; 2006 Oct; 129(Pt 10):2620-7. PubMed ID: 16951409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MRI follow-up in multiple sclerosis. A guideline for quality assurance].
    Gass A; Radü EW; Filippi M; Kappos L
    Rofo; 1999 Jun; 170(6):581-6. PubMed ID: 10420909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
    Zivadinov R
    Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.